Titlebook: Novel Inhibitors of Leukotrienes; Giancarlo Folco,Bengt Samuelsson,Robert C. Murphy Book 1999 Springer Basel AG 1999 asthma.cell.developme

autoantibodies

書目名稱Novel Inhibitors of Leukotrienes影響因子(影響力)




書目名稱Novel Inhibitors of Leukotrienes影響因子(影響力)學科排名




書目名稱Novel Inhibitors of Leukotrienes網(wǎng)絡(luò)公開度




書目名稱Novel Inhibitors of Leukotrienes網(wǎng)絡(luò)公開度學科排名




書目名稱Novel Inhibitors of Leukotrienes被引頻次




書目名稱Novel Inhibitors of Leukotrienes被引頻次學科排名




書目名稱Novel Inhibitors of Leukotrienes年度引用




書目名稱Novel Inhibitors of Leukotrienes年度引用學科排名




書目名稱Novel Inhibitors of Leukotrienes讀者反饋




書目名稱Novel Inhibitors of Leukotrienes讀者反饋學科排名

BIPED

,The development of zafirlukast (Accolate?) and the Zeneca series of peptidyl-leukotriene receptor a LrE.. Together they account for the biological activity of slow-reacting substance of anaphylaxis (SRS-A), which was discovered nearly 40 years ago when it was distinguished from histamine by its ability to produce a slowly developing and long-lasting contraction of isolated guinea pig ileum [2].

我不重要

DNR215

1422-7746 es a new approach in presenting information of particular interest to both scientists and clinicians in the fields of asthma, inflammation and allergic diseases.978-3-0348-9736-5978-3-0348-8703-8Series ISSN 1422-7746 Series E-ISSN 2296-4525

詞匯

incarcerate

Metabolism of leukotrienes and formation of new leukotriene structures,pathways involved in metabolic processing are common to a host of other endogenous biochemical substances, in particular eicosanoids such as prostaglandins and thromboxanes. However, there are several enzymes rather specific for certain leukotrienes, suggesting a more unique role for such metabolic events mediated by these enzymes.

LASH

adequate-intake

四指套

The development of iralukast: A member of the Novartis series of cysteinyl leukotriene antagonists,lukast (AccolateTM, ICI 204,219) and montelukast (SingulairTM, MK 0476) are available on the market as treatment for asthma [1–6]. Further compounds, such as iralukast (CGP 45715A) are in development for this indication [7,8].

Militia

Book 1999w chapters on the main aspects of basic and applied leukotriene research are written by leading specialists in the field, and the volume takes a new approach in presenting information of particular interest to both scientists and clinicians in the fields of asthma, inflammation and allergic diseases.